In brief: effervescent alendronate.
D000284:Administration, Oral; D019386:Alendronate / Q000008:administration & dosage* / Q000009:adverse effects; D050071:Bone Density Conservation Agents / Q000008:administration & dosage* / Q000009:adverse effects; D017277:Drug Approval; D006801:Humans; D010024:Osteoporosis / Q000188:drug therapy*; D013607:Tablets; D014481:United States; D014486:United States Food and Drug Administration
D050071:Bone Density Conservation Agents; D013607:Tablets; D019386:Alendronate